| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 2.462 | 63.175 | 120.524 | 174.450 | 322.830 | 536.641 | 708.286 |
| Total Income - EUR | - | - | - | 2.462 | 63.175 | 120.524 | 175.129 | 322.830 | 536.641 | 708.286 |
| Total Expenses - EUR | - | - | - | 4.034 | 72.625 | 120.449 | 159.628 | 303.565 | 496.151 | 634.528 |
| Gross Profit/Loss - EUR | - | - | - | -1.572 | -9.450 | 75 | 15.501 | 19.265 | 40.490 | 73.758 |
| Net Profit/Loss - EUR | - | - | - | -1.646 | -11.346 | -1.766 | 13.750 | 16.198 | 33.900 | 61.402 |
| Employees | - | - | - | 0 | 0 | 1 | 2 | 2 | 2 | 4 |
Check the financial reports for the company - Vonov Bioprod S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 26 | 4.829 | 7.105 | 52.023 | 41.256 | 32.665 | 152.201 |
| Current Assets | - | - | - | 6.027 | 21.942 | 12.950 | 31.072 | 41.629 | 93.876 | 171.791 |
| Inventories | - | - | - | 5.005 | 7.320 | 8.598 | 26.678 | 8.490 | 51.805 | 134.400 |
| Receivables | - | - | - | 0 | 0 | 243 | 3.568 | 1.601 | 5.554 | 1.013 |
| Cash | - | - | - | 1.022 | 14.556 | 3.909 | 341 | 30.479 | 30.592 | 34.476 |
| Shareholders Funds | - | - | - | -1.603 | -12.918 | -14.438 | -368 | 15.828 | 49.680 | 108.619 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 7.656 | 39.689 | 34.494 | 83.463 | 67.056 | 77.784 | 215.845 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Vonov Bioprod S.r.l.